Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
1.660
-0.040 (-2.35%)
Mar 31, 2025, 2:30 PM EDT - Market open

Immix Biopharma Statistics

Total Valuation

Immix Biopharma has a market cap or net worth of $46.02 million. The enterprise value is $29.97 million.

Market Cap 46.02M
Enterprise Value 29.97M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

Immix Biopharma has 27.72 million shares outstanding. The number of shares has increased by 63.11% in one year.

Current Share Class 27.72M
Shares Outstanding 27.72M
Shares Change (YoY) +63.11%
Shares Change (QoQ) +0.47%
Owned by Insiders (%) 20.99%
Owned by Institutions (%) 15.65%
Float 17.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.53
P/TBV Ratio 3.51
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.08.

Current Ratio 2.33
Quick Ratio 2.26
Debt / Equity 0.08
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -147.33% and return on invested capital (ROIC) is -92.84%.

Return on Equity (ROE) -147.33%
Return on Assets (ROA) -66.11%
Return on Invested Capital (ROIC) -92.84%
Return on Capital Employed (ROCE) -159.00%
Revenue Per Employee n/a
Profits Per Employee -$1.27M
Employee Count 17
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Immix Biopharma has paid $41,037 in taxes.

Income Tax 41,037
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -44.63% in the last 52 weeks. The beta is 0.25, so Immix Biopharma's price volatility has been lower than the market average.

Beta (5Y) 0.25
52-Week Price Change -44.63%
50-Day Moving Average 1.84
200-Day Moving Average 1.92
Relative Strength Index (RSI) 45.15
Average Volume (20 Days) 46,664

Short Selling Information

The latest short interest is 367,356, so 1.33% of the outstanding shares have been sold short.

Short Interest 367,356
Short Previous Month 386,334
Short % of Shares Out 1.33%
Short % of Float 2.04%
Short Ratio (days to cover) 6.52

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -22.67M
Pretax Income -18.18M
Net Income -21.61M
EBITDA -22.64M
EBIT -22.67M
Earnings Per Share (EPS) -$0.76
Full Income Statement

Balance Sheet

The company has $17.68 million in cash and $1.07 million in debt, giving a net cash position of $16.61 million or $0.60 per share.

Cash & Cash Equivalents 17.68M
Total Debt 1.07M
Net Cash 16.61M
Net Cash Per Share $0.60
Equity (Book Value) 13.25M
Book Value Per Share 0.48
Working Capital 11.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.60 million and capital expenditures -$1.18 million, giving a free cash flow of -$15.77 million.

Operating Cash Flow -14.60M
Capital Expenditures -1.18M
Free Cash Flow -15.77M
FCF Per Share -$0.57
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Immix Biopharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -63.11%
Shareholder Yield -63.11%
Earnings Yield -46.41%
FCF Yield -33.87%

Analyst Forecast

The average price target for Immix Biopharma is $7.00, which is 321.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 321.69%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1